Multiple Myeloma

Celgene's Revlimid Passes EU Safety Review
TheStreet.com
Fri, 09/23/11 - 12:03 pm
Celgene
Revlimid
Europe
EU
Multiple Myeloma
Revlimid side effects linked to protein in study
Reuters, UK
Tue, 08/9/11 - 10:10 am
Multiple Myeloma
Celgene
Revlimid
YM BioSciences JAK Inhibitor CYT387 Shown Active in Multiple Myeloma
Yahoo
Thu, 08/4/11 - 10:56 am
JAK inhibitors
CYT387
Multiple Myeloma
YM BioSciences
Celgene’s Blood-Cancer Treatment Backed by U.K. Cost Agency
Bloomberg
Tue, 07/26/11 - 09:57 pm
UK
Celgene
thalidomide
Multiple Myeloma
Ligand will start new study of multiple myeloma drug, plans to file for approval in mid-2013
Yahoo/AP
Wed, 06/22/11 - 10:22 pm
Ligand
Multiple Myeloma
melphalan
Keryx Biopharmaceuticals vs. AEterna Zentaris
Seeking Alpha
Thu, 06/9/11 - 10:17 am
Aeterna Zentaris
Keryx
perifosine
colorectal cancer
Multiple Myeloma
Celgene Stock Falls On Worries About Secondary Cancers
Forbes
Fri, 05/6/11 - 08:37 am
Celgene
cancer
Multiple Myeloma
Revlimid
Celgene Poised to Bounce Back After Revlimid Safety Blues
Seeking Alpha
Mon, 04/25/11 - 10:25 pm
Celgene
Revlimid
drug safety
Multiple Myeloma
Onyx multiple myeloma drug wins FDA fast-track status
Bizjournals.com
Tue, 02/1/11 - 08:20 am
ONYX Pharmaceuticals
Multiple Myeloma
FDA
fast track
Carfilzomib
Celgene: Revlimid Cancer Risk Knocks Stock
TheStreet.com
Mon, 12/6/10 - 11:04 am
Celgene
Revlimid
Multiple Myeloma
Onyx Delays Cancer Drug Application As FDA Asks for More Data
Motley Fool
Fri, 10/8/10 - 08:12 am
ONYX Pharmaceuticals
FDA
Carfilzomib
Multiple Myeloma
Celgene's Revlimid Marches on
Yahoo/Zacks
Sat, 08/21/10 - 01:35 pm
Celgene
Revlimid
Multiple Myeloma
Onyx's Next Blockbuster?
Forbes
Mon, 07/26/10 - 11:02 am
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Celgene International Sarl Releases Results of Phase II Study on Multiple Myeloma Patients
Trading Markets
Sat, 06/12/10 - 10:14 am
Cellgene
Multiple Myeloma
dexamethasone
pomalidomide
lenalidomide
HGS trial showed no difference in disease response
Marketwatch
Wed, 06/9/10 - 08:32 am
Human Genome Sciences
mapatumumab
Multiple Myeloma
Randomized Phase III Study Comparing REVLIMID(R) Plus Melphalan and Prednisone (MPR) Compared to Autologous Stem Cell Transplant Presented at ASCO
MarketWatch
Sun, 06/6/10 - 12:34 pm
Multiple Myeloma
Revlimid
melphalan
autologous stem cell transplant
Celgene
Celgene (CELG) Is A Top-Growth Biotech Stock; High P/E Multiple And Global Expansion Of Its Myeloma Franchise And REVLIMID Makes It A Top Stock Pick
Yahoo/Wall St. Transcript
Sat, 04/10/10 - 11:39 am
Celgene
Revlimid
Multiple Myeloma
It's the End of Days for Celgene's Multiple-Myeloma Drug Franchise
BNET Pharma
Tue, 02/16/10 - 05:14 pm
Multiple Myeloma
Celgene
Revlimid
Celgene's Revlimid meets cancer study goal
Yahoo/AP
Fri, 12/18/09 - 10:43 am
Revlimid
cancer
Celgene
clinical trials
Multiple Myeloma
High Hopes Remain for Celgene's Revlimid
Seeking Alpha
Thu, 12/10/09 - 07:54 am
Celgene
Revlimid
Multiple Myeloma

Pages